[AHA] Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial |
|
This post will be closed automatically in 2026-10-29 19:20
Reward10points
|
20
Contribution ofAPOEGenetic Variants to Dyslipidemia
10
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial
10
Percutaneous Solutions for Tricuspid Regurgitation: Current Approved Options and Identifying Ideal Candidates
10
GCKIII (Germinal Center Kinase III) Kinases STK24 and STK25 (Serine/Threonine Kinase 24 and 25) Inhibit Cavernoma Development
10
Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease